Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 and is based in Freehold, New Jersey.
Metrics to compare | ENDY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENDYPeersSector | |
---|---|---|---|---|
P/E Ratio | −6.3x | −2.9x | −0.6x | |
PEG Ratio | 0.02 | 0.00 | 0.00 | |
Price/Book | 0.9x | 3.9x | 2.6x | |
Price / LTM Sales | 0.6x | 2.2x | 3.2x | |
Upside (Analyst Target) | - | 31.9% | 46.2% | |
Fair Value Upside | Unlock | 10.0% | 7.0% | Unlock |